| FDA New, GMP Do Clinical Phase II, III Intermediates GMP Custom synthesis, Full Document R&D Center: 8000 sq, More than 100 hoods Pilot Plant: 20000sq, 40 reactors from 5-200L Manufacturing Site: 800000sq, 40 reactors from 100-5000L Web: www.eosmedchem.com Email: info@eosmedchem.com; eosmedchem@gmail.com This is my R&D youtube: https://youtu.be/r5cJdXKNXHk |
| Selenazofurin, 83705-13-9, Selenazofurin Intermediate 23316-67-8, stock 407.9g, white powder, assay by HPLC 98.6%, HNMR, LCMS we supply. |
| Selenazofurin, 83705-13-9, Selenazofurin Intermediate 83705-10-6, stock 508.4g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
| Selenazofurin, 83705-13-9, Selenazofurin Intermediate 70-23-5, stock 937.7g, white powder, assay by HPLC 99.1%, HNMR, LCMS we supply. |
| Selenazofurin, 83705-13-9, Selenazofurin Intermediate 83705-11-7, stock 763.2g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
| Selenazofurin, 83705-13-9, Selenazofurin Intermediate /, stock 491.8g, white powder, assay by HPLC 99.7%, HNMR, LCMS we supply. |
